Christophe Valat

CellProthera SAS operates as a holding company with interests in medical studies on heart diseases. The firm focuses on the development of a stem cell therapy for the regeneration of myocardial tissue allowing the prevention of chronic heart failure following acute myocardial infarct by injecting a cell graft containing antilogous adult stem cells sampled directly from the patient. The company was founded by Philippe H?non in April 2008 and is headquartered in Mulhouse, France.

Serial Genetics designs, develops and sells genetics analysis kits based on its proprietary technology, HairLoop and mutation discovery tools, based on the Endo-1 enzyme. Serial Genetics is an active partner of the 'Medicen Paris Region' competitiveness hub, dedicated to health and pharmaceutical research. Based in Evry, France, Serial Genetics is ideally situated in the hearth of the Genopole, the French largest cluster of biotech companies and genetic academic labs.

IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom.